Le Lézard
Classified in: Health
Subject: PDT

Grand Opening of Affordable Dentures & Implants in Vista, California Enhances Patient Access to Quality, Affordable Dental Care


Practice joins Affordable Care's national network of supported dental practices  

VISTA, Calif., May 15, 2024 /PRNewswire/ -- The new Affordable Dentures & Implants practice in Vista, California, located 510 Hacienda Drive, Suite 108-A, is now open. The practice joins the nation's largest provider network of dental practices ? supported by Affordable Care ? that provide tooth replacement services. 

From extractions and partial dentures to full dentures and dental implants, including implant-secured dentures, Affordable Dentures & Implants in Vista offers quality, affordable tooth replacement care.

Practice Owner Ernesto Delgado Perez, DDS, General Dentist, and the team at Affordable Dentures & Implants in Vista are proud to offer professional and compassionate care to patients. The practice is open 9 a.m. to 6 p.m. Monday through Friday. For more information, or to schedule an appointment, visit the practice website, or call 1-800-DENTURE.

About Affordable Dentures & Implants®
Affordable Dentures & Implants practices make tooth replacement affordable for everyone. Founded in 1975 in Kinston, North Carolina, Affordable Dentures & Implant practices form the largest network of dental providers in the U.S., solely focused on tooth replacement solutions -- including dentures, dental implants, and fixed arch solutions -- with more than 425 locations across 42 states. The mission of Affordable Dentures & Implants practices is to provide a smile for every budget, delivered with compassion, dignity, and respect. Visit affordabledentures.com, and follow us on Facebook, Instagram and LinkedIn.

About Affordable Care
Affordable Care is America's largest dental support organization exclusively focused on tooth replacement services. Our team proudly supports more than 450 affiliated dental practices, including Affordable Dentures & Implants, DDS Dentures + Implant Solutions and Advanced Dental Implant Center, in 43 states by providing innovative, non-clinical business and administrative support services to assist affiliated dental practices in providing their patients with access to high-quality, affordable tooth replacement solutions. More than 8 million patients have received care at an Affordable Care-supported dental practice. Visit affordablecare.com and follow us on LinkedIn and X (formerly Twitter). 

SOURCE Affordable Care


These press releases may also interest you

at 18:05
New Blood Test Predicts Recurrence of Breast Cancer, Months or Even Years Before Relapse
A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown. A team from The Institute of Cancer Research, London, used an ultra-sensitive liquid biopsy to...

at 17:35
Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma
Genmab A/S today announced new efficacy and safety data from two ongoing Phase 1/2 clinical trials evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, in adult patients with certain types of follicular lymphoma...

at 14:35
TAGRISSO® (osimertinib) reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial
Positive results from the LAURA Phase III trial showed AstraZeneca's TAGRISSO® (osimertinib) demonstrated a statistically significant and highly clinically meaningful improvement in progression-free survival (PFS) for patients with unresectable,...

at 12:35
CatalYm Reports Impressive and Lasting Responses Including Multiple Complete Responses in Heavily Pretreated, Late- to Last-Line Metastatic NSCLC, Urothelial and Hepatocellular Cancer Patients Treated with Visugromab/Nivolumab Combination
CatalYm today announced positive new follow-up results from its ongoing "GDFATHER" Phase 1/2a trial (GDF-15 Antibody-mediaTed Human Effector Cell Relocation Phase 1/2a) (NCT04725474) in an oral presentation at the American Society of Clinical...

at 11:35
KFSHRC Successfully Treats Severe Case of "Xanthoma" After 26 Years of Suffering
In an era where healthcare innovation is paramount, KFSHRC Jeddah has made headway in the treatment of severe Xanthoma through the deployment of a modified plasma exchange protocol. This milestone underscores KFSHRC's position as a trailblazer in...

at 11:00
Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma
GSK plc (LSE/NYSE: GSK) today announced positive results from an interim analysis of the DREAMM-8 phase III head-to-head trial evaluating belantamab mafodotin, in combination with pomalidomide plus dexamethasone (PomDex), versus a standard of care,...

More news about Health...


News published on and distributed by: